Pulmonary hemodynamic response to acute combination and monotherapy with sildenafil and brain natriuretic peptide in rats with monocrotaline-induced pulmonary hypertension

American Journal of the Medical Sciences

Volumn 339, Issue 1, 2010, Pages 55-59

  Carlino, Carl ^a   Tobias, Joseph D ^a   Schneider, Rebecca I ^a   Heller, Randall L ^a   Alpert, Martin A ^a   Grueber, Ryan E ^a   Dellsperger, Kevin C ^a,b   Demarco, Vincent G ^a,b  

^a University of Missouri   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

Cyclic guanosine monophosphate; Natriuretic peptides; Phosphodiesterase inhibitors; Pulmonary arterial hypertension; Sildenafil

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; MONOCROTALINE; SILDENAFIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENTIATION; HEART RATE; HEART RIGHT VENTRICLE PRESSURE; LOW DRUG DOSE; LUNG HEMODYNAMICS; MALE; MEAN ARTERIAL PRESSURE; MONOTHERAPY; NONHUMAN; PULMONARY HYPERTENSION; RAT;

EID: 75449105815     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181c078d7     Document Type: Article

References (29)

1. Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med 2004;351:1655-1665
2. Rubin LJ, Badesch DB. Evaluation and management of the patient with pulmonary arterial hypertension. Ann Intern Med 2005;143: 282-292
3. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004;351:1425-1436
4. Clozel M, Hess P, Rey M, et al. Bosentan, sildenafil, and their combination in the monocrotaline model of pulmonary hypertension in rats. Exp Biol Med (Maywood) 2006;231:967-973
5. Hoeper MM, Galiè N, Simonneau G, et al. New treatments for pulmonary arterial hypertension. Am J Respir Crit Care Med 2002;165: 1209-1216 (Pubitemid 34461731)
6. Channick RN, Simonneau G, Sitbon O, et al. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study. Lancet 2001;358: 1119-1123 (Pubitemid 32971843)
7. Rubin LJ, Badesch DB, Barst RJ, et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002;346:896-903.
8. Steiner MK, Preston IR, Klinger JR, et al. Pulmonary hypertension: inhaled nitric oxide, sildenafil and natriuretic peptides. Curr Opin Pharmacol 2005;5:245-250
9. Pauvert O, Bonnet S, Rousseau E, et al. Sildenafil alters calcium signaling and vascular tone in pulmonary arteries from chronically hypoxic rats. Am J Physiol Lung Cell Mol Physiol 2004;287:L577- 83.
10. Preston IR, Hill NS, Gambardella LS, et al. Synergistic effects of ANP and sildenafil on cGMP levels and amelioration of acute hypoxic pulmonary hypertension. Exp Biol Med (Maywood) 2004;229:920-925
11. Zhao L, Mason NA, Strange JW, et al. Beneficial effects of phosphodiesterase 5 inhibition in pulmonary hypertension are influenced by natriuretic peptide activity. Circulation 2003;107:234-237
12. Pauvert O, Lugnier C, Keravis T, et al. Effect of sildenafil on cyclic nucleotide phosphodiesterase activity, vascular tone and calcium signaling in rat pulmonary artery. Br J Pharmacol 2003;139:513-522
13. Galie N, Ghofrani HA, Torbicki A, et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 2005;353:2148-2157 (Pubitemid 41653106)
14. Schermuly RT, Kreisselmeier KP, Ghofrani HA, et al. Chronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in rats. Am J Respir Crit Care Med 2004;169:39-45.
15. Mikhail GW, Prasad SK, Li W, et al. Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects. Eur Heart J 2004;25:431-436
16. Raja SG, Nayak SH. Sildenafil: emerging cardiovascular indications. Ann Thorac Surg 2004;78:1496-1506
17. Klinger JR, Thaker S, Houtchens J, et al. Pulmonary hemodynamic responses to brain natriuretic peptide and sildenafil in patients with pulmonary arterial hypertension. Chest 2006;129:417-425
18. Preston IR, Klinger JR, Houtches J, et al. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension. Respir Med 2005;99:1501-1510
19. Turk JR. Physiologic and pathophysiologic effects of natriuretic peptides and their implications in cardiopulmonary disease. J Am Vet Med Assoc 2000;216:1970-1976
20. Klinger JR, Warburton RR, Pietras L, et al. Brain natriuretic peptide inhibits hypoxic pulmonary hypertension in rats. J Appl Physiol 1998; 84:1646-1652 (Pubitemid 28225903)
21. Chen HH, Burnett JC. Natriuretic peptides in the pathophysiology of congestive heart failure. Curr Cardiol Rep 2000;2:198-205.
22. Klinger JR, Houtchens J, Thaker S, et al. Acute cardiopulmonary hemodynamic effects of brain natriuretic peptide in patients with pulmonary arterial hypertension. Chest 2005;128(6 suppl):618S-9S.
23. Kurian DC, Wagner IJ, Klapholz M. Nesiritide in pulmonary hypertension. Chest 2004;126:302-305
24. Cataliotti A, Schirger JA, Martin FL, et al. Oral human brain natriuretic peptide activates cyclic guanosine 3′,5′-monophosphate and decreases mean arterial pressure. Circulation 2005;112:836-840
25. Chen HH, Redfield MM, Nordstrom LJ, et al. Subcutaneous administration of the cardiac hormone BNP in symptomatic human heart failure. J Card Fail 2004;10:115-119
26. Itoh T, Nagaya N, Fujii T, et al. A combination of oral sildenafil and beraprost ameliorates pulmonary hypertension in rats. Am J Respir Crit Care Med 2004;169:34-38 (Pubitemid 38233886)
27. Ito KM, Sato M, Ushijima K, et al. Alterations of endothelium and smooth muscle function in monocrotaline-induced pulmonary hypertensive arteries. Am J Physiol Heart Circ Physiol 2000;279:H1786-95.
28. Hessel MH, Steendijk P, de Adel B, et al. Characterization of right ventricular function after monocrotaline-induced pulmonary hypertension in the intact rat. Am J Physiol Heart Circ Physiol 2006;291: 2424-2430
29. Steffen BT, Lees SJ, Booth FW. Anti-TNF treatment reduces rat skeletal muscle wasting in monocrotaline-induced cardiac cachexia. J Appl Physiol 2008;105:1950-1958